Back to search

Japan· JP-2399005R1210

ドンペリドン

A domperidone product containing ドンペリドン, registered in Japan by 沢井製薬, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

On Japan’s NHI price listATC A03FA03

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedドンペリドンATCA03FA03REGISTER NO.JP-2399005R1210PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Domperidone is registered in 13 of 19 countries.

Countries holding a registration under ATC A03FA03 (domperidone), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 5 of them publish a price we can compare per daily dose

Domperidone · ATC A03FA03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of domperidone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.21 in France to $1.03 in Switzerland — a ×4.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Domperidone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.03
  • FR France$0.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ドンペリドン
Manufacturer
沢井製薬
Country
Japan (JP)
ATC code
A03FA03
ATC class
Domperidone
Defined daily dose
30 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

52 interactions on record for domperidone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Domperidone · interactions on record

52 records

52 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Domperidone in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All domperidone products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Motilium
  • Belgium · Domperidon Ab, Domperidon Teva
  • Bulgaria · Кости
  • Cyprus · Costi, Motilium
  • Germany · Domperidon Abz, Domperidon Hexal
  • Denmark · Domperidon Alternova
  • Spain · Domperidona Gamir, Domperidona Pensa
  • France · Domperidone Almus, Domperidone Arrow
  • United Kingdom (Northern Ireland) · Domperidone, Domperidone Activase Pharmaceuticals
  • Greece · Cilroton, Domperidone Iasis
  • Croatia · Domperidon Stada
  • Hungary · Domperidon Ep
  • Ireland · Domerid, Domerid Relief
  • Italy · Domperidone Abc, Domperidone Doc Generici
  • Liechtenstein · Motilium
  • Lithuania · Oroperidys
  • Luxembourg · Domperidone Eg, Domperidone Instant Eg
  • Malta · Cinet, Costi
  • Netherlands · Domperidon Accord, Domperidon Cf
  • Portugal · Cinet, Domperidona Aurovitas
  • Romania · Domotil
  • Sweden · Domperidon Ebb
  • Slovakia · Costi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8a6f3e2-7e09-4e02-83a2-93661b37cb30
GET /v1/drugs/a8a6f3e2-7e09-4e02-83a2-93661b37cb30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "1%1g",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2399005R1210",
  "category": "内用薬",
  "price_yen": 6.9,
  "generic_name": "ドンペリドン",
  "product_name_jp": null,
  "therapeutic_class": "2399",
  "transitional_expiry": null
}

See everything about domperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.